Ten rival pharmaceutical companies have joined forces with the National Institutes of Health in a new initiative to research Alzheimer’s, Type 2 diabetes, lupus and rheumatoid arthritis. The unlikely pact between the competing firms — which includes big names…
By Sarah Corapi
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.